title: Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome.
abstract: Childhood ataxia with diffuse central nervous system hypomyelination syndrome (CACH) is a recently described leukodystrophy of unknown etiology. To characterize the neuropathological features and gain insight as to the pathogenesis of this disorder, we studied cerebral tissue from six patients with the CACH syndrome. Evaluation of toluidine blue-stained, semithin sections of white matter from CACH patients disclosed unusual cells with "foamy" cytoplasm, small round nuclei and fine chromatin. Electron microscopy (EM) revealed cells in the white matter with abundant cytoplasm containing many mitochondria and loosely clustered, membranous structures, but lacking the lysosomal structures seen in macrophages. Further analysis of tissue sections with antibodies and special stains demonstrated that the abnormal cells with abundant cytoplasm labeled with oligodendroglial markers, but did not react with macrophage or astrocytic markers. Double immunolabeling with macrophage and oligodendroglial markers clearly distinguished macrophages from the "foamy" oligodendroglial cells (FODCs). Proteolipid protein (PLP) mRNA in situ hybridization demonstrated PLP mRNA transcripts in a high proportion of oligodendrocytes in CACH patients compared to control patients, and PLP mRNA transcript signal in cells, morphologically consistent with FODCs. Normal and pathological brain control tissues did not contain FODCs. These neuropathological findings will be useful pathological identifiers of CACH, and may provide clues to the pathogenesis of this disorder.
authors.affiliation: Department of Neuropathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA. Wong@AFIP.OSD.MIL
authors.forename: K
authors.initials: K
authors.lastname: Wong
authors.forename: R C
authors.initials: RC
authors.lastname: Armstrong
authors.forename: K A
authors.initials: KA
authors.lastname: Gyure
authors.forename: A L
authors.initials: AL
authors.lastname: Morrison
authors.forename: D
authors.initials: D
authors.lastname: Rodriguez
authors.forename: R
authors.initials: R
authors.lastname: Matalon
authors.forename: A B
authors.initials: AB
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Wollmann
authors.forename: E
authors.initials: E
authors.lastname: Gilbert
authors.forename: T Q
authors.initials: TQ
authors.lastname: Le
authors.forename: C A
authors.initials: CA
authors.lastname: Bradley
authors.forename: K
authors.initials: K
authors.lastname: Crutchfield
authors.forename: R
authors.initials: R
authors.lastname: Schiffmann
mesh_terms: D001259:Ataxia / Q000150:complications* / Q000378:metabolism / Q000473:pathology*; D015415:Biomarkers; D001706:Biopsy; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005487:Foam Cells / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D020279:Hereditary Central Nervous System Demyelinating Diseases / Q000150:complications* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007223:Infant; D008297:Male; D009836:Oligodendroglia / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D015415:Biomarkers; D012333:RNA, Messenger